These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Retinal detachments after the use of phospholine iodide. Lemcke HH; Pischel DK Trans Pac Coast Otoophthalmol Soc Annu Meet; 1966; 47():157-63. PubMed ID: 5955105 [No Abstract] [Full Text] [Related]
64. [Muscle flaccidity as a leading and warning symptom in drug therapy and poisonings]. Neuhaus GA Verh Dtsch Ges Inn Med; 1978; (84):852-62. PubMed ID: 369214 [No Abstract] [Full Text] [Related]
66. Dose responses of human intra-ocular pressure to various concentrations of echothiophate iodide. Stockdill P; Drance SM Trans Ophthalmol Soc U K (1962); 1965; 85():537-43. PubMed ID: 5227202 [No Abstract] [Full Text] [Related]
67. Glaucoma, miotic therapy and cataract. 3. Visual loss due to lens changes in glaucoma eyes treated with paraoxon (Mintacol), echothiophate (phospholine iodide) or pilocarpine. Axelsson U Acta Ophthalmol (Copenh); 1968; 46(4):831-45. PubMed ID: 5755701 [No Abstract] [Full Text] [Related]
68. Therapy of bronchospasm from muscarinic drugs. Smith RB; Waterman PM Ann Intern Med; 1978 Aug; 89(2):289-90. PubMed ID: 677604 [No Abstract] [Full Text] [Related]
69. Cholinesterase in red cells. Kinyon GE N Engl J Med; 1969 Mar; 280(13):729-30. PubMed ID: 5766090 [No Abstract] [Full Text] [Related]
70. Glaucoma, miotic therapy and cataract. I. The frequency of anterior subcapsular vacuoles in glaucoma eyes treated with echothiophate (Phospholine Iodide), pilocarpine or pilocarpine-eserine, and in nonglaucomatous untreated eyes with common senile cataract. Axelsson U Acta Ophthalmol (Copenh); 1968; 46(1):83-98. PubMed ID: 5694669 [No Abstract] [Full Text] [Related]
71. [Comparison of the effect of pilocarpine and echothiophate on the ocular pressure and outflow facility of the aqueous humor]. Barsam PC Bull Mem Soc Fr Ophtalmol; 1973; 86(0):139-43. PubMed ID: 4794285 [No Abstract] [Full Text] [Related]
72. Angle-closure glaucoma precipitated by the use of phospholine iodide for esotropia in a child. Jones DE; Watson DM Br J Ophthalmol; 1967 Nov; 51(11):783-5. PubMed ID: 6060809 [No Abstract] [Full Text] [Related]
73. Lens opacities in glaucoma patients on phospholine iodide therapy. De Roetth A Trans Ophthalmol Soc U K (1962); 1966; 86():89-100. PubMed ID: 5226620 [No Abstract] [Full Text] [Related]
74. [Experiences with phospholine iodide in the therapy of glaucoma]. Payer H Wien Med Wochenschr; 1969 Feb; 119(6):115-6. PubMed ID: 5786240 [No Abstract] [Full Text] [Related]
75. Lens opacities in glaucoma patients on phospholine iodide therapy. De Roetth A Am J Ophthalmol; 1966 Oct; 62(4):619-28. PubMed ID: 5929123 [No Abstract] [Full Text] [Related]
76. [Notes on 0.03% phospholine iodide, with more than 4 years' experience]. Corbel MM; Leser C; François P Bull Soc Ophtalmol Fr; 1976 Mar; 76(3):249-50. PubMed ID: 1024748 [No Abstract] [Full Text] [Related]
78. Effect of echothiophate therapy on the metabolism of succinylcholine in man. Cavallaro RJ; Krumperman LW; Kugler F Anesth Analg; 1968; 47(5):570-4. PubMed ID: 5691696 [No Abstract] [Full Text] [Related]
79. Glaucoma, miotic therapy and cataract. VI. Experimental studies on the guinea pig eye. Axelsson U Acta Ophthalmol (Copenh); 1969; 47(4):1057-67. PubMed ID: 5394839 [No Abstract] [Full Text] [Related]
80. Echothiophate iodide treatment of glaucoma in pregnancy. Birks DA; Prior VJ; Silk E; Whittaker M Arch Ophthalmol; 1968 Mar; 79(3):283-5. PubMed ID: 5640850 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]